Monthly Archives: November 2012

U.S. action on SENSA false advertising claims; TGA does nothing

“Sensa Products, LLC and its parent corporation Intelligent Beauty Inc. has agreed to pay more than $900,000 to settle a U.S. false advertising lawsuit. This lawsuit was filed in Santa Cruz County by nine California district attorneys for the Counties … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , | Leave a comment

ACCC Pre-decision conference: Medicines Australia Code

At yesterday’s meeting with the ACCC, Ian Haines, Bob Arnold, Carol Bennett, Ray Moynihan and I argued that full disclosure of the relationship between therapeutic goods companies, physicians and other stakeholders is crucial. I tabled a petition that currently has … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | Leave a comment

Petition to ACCC on Medicines Australia Code Authorisation

While collaborations between industry and health professionals are desirable, widespread financial ties bring significant risks of undue influence on professional judgements, potentially jeopardizing the integrity of medical research, education, clinical practice and public trust in medicine, according to a landmark … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , | Leave a comment

Swisse “research”

Swisse Press Release Nov 2, 2012 “Complementary medicines save the Australian economy a staggering $7.66 billion per annum through workers having fewer sick days, visiting their general practitioner less frequently and taking fewer prescription medicines” This result came from extrapolating … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , | Leave a comment